{
  "trial_id": "NCT00213980",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, BMI, menopausal status, baseline bone mineral density (BMD), breast cancer stage, axillary node status, prior chemotherapy, prior hormone therapy, calcium and vitamin D intake, physical activity level, smoking status, alcohol consumption, family history of osteoporosis, baseline serum calcium levels, baseline serum vitamin D levels.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "menopausal status"
        ],
        [
          "Lymph Node Status",
          "axillary node status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment",
        "Tumor Size",
        "Endocrine Therapy During Year 1 on Study",
        "Performance Status"
      ],
      "remaining_candidate_features": [
        "BMI",
        "baseline bone mineral density (BMD)",
        "breast cancer stage",
        "prior chemotherapy",
        "prior hormone therapy",
        "calcium and vitamin D intake",
        "physical activity level",
        "smoking status",
        "alcohol consumption",
        "family history of osteoporosis",
        "baseline serum calcium levels",
        "baseline serum vitamin D levels"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Menopausal Status, Breast Cancer Stage, Baseline Bone Mineral Density (BMD), Use of Hormone Replacement Therapy, Calcium and Vitamin D Intake, Physical Activity Level, Smoking Status, Alcohol Consumption,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Tumor Size",
        "Lymph Node Status",
        "Endocrine Therapy During Year 1 on Study",
        "Performance Status"
      ],
      "remaining_candidate_features": [
        "Menopausal Status",
        "Breast Cancer Stage",
        "Baseline Bone Mineral Density (BMD)",
        "Use of Hormone Replacement Therapy",
        "Calcium and Vitamin D Intake",
        "Physical Activity Level",
        "Smoking Status",
        "Alcohol Consumption"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Postmenopausal Status, Region of Enrollment, Breast Cancer Stage, Axillary Node Status, Prior Bisphosphonate Use, Baseline Bone Mineral Density.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Lymph Node Status",
          "Axillary Node Status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Tumor Size",
        "Endocrine Therapy During Year 1 on Study",
        "Performance Status"
      ],
      "remaining_candidate_features": [
        "Postmenopausal Status",
        "Breast Cancer Stage",
        "Prior Bisphosphonate Use",
        "Baseline Bone Mineral Density."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ethnicity, body mass index (BMI), years since menopause, breast cancer stage, axillary node status, history of osteoporosis, history of fractures, current use of hormone replacement therapy (HRT), current use of aromatase inhibitors, current use of chemotherapy, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "years since menopause"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Lymph Node Status",
          "axillary node status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Tumor Size",
        "Endocrine Therapy During Year 1 on Study",
        "Performance Status"
      ],
      "remaining_candidate_features": [
        "race",
        "body mass index (BMI)",
        "breast cancer stage",
        "history of osteoporosis",
        "history of fractures",
        "current use of hormone replacement therapy (HRT)",
        "current use of aromatase inhibitors",
        "current use of chemotherapy",
        "smoking status"
      ]
    }
  }
}